Back to 
BNP Paribas Financial MarketsENENGN
BNP Paribas Financial MarketsENENGN1 quarters
Position history for BNP Paribas Financial Markets's holdings in enGene Therapeutics Inc.
Yes. BNP Paribas Financial Markets holds 25,419 shares of ENGN (enGene Therapeutics), worth $43,975, as of its Q2 2026 13F filing.
Current Value
$43,975
Current Shares
25,419
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of ENGN: Ameriprise Financial Inc., Marshall Wace, LLP, Balyasny Asset Management L.P., Millennium Management LLC, Renaissance Technologies LLC